Sharekhan bullish despite pharma’s underperformance; backs Cipla, Lupin and 3 more for up to 16% gains – Pharma Rally
Sector outperformer, Torrent Pharmaceuticals, has delivered 1-year returns of 16. It has another 14% upside, says this brokerage. Company’s PAT rose 16% YoY while its revenue increased 9% over the corresponding quarter of the last financial year.Buy Sun Pharma at Rs 1,805 | Target: Rs 1,968 | Upside: 9%Sun Pharmaceutical Industries’ 12-month returns stand at…